Zura Bio Limited (ZURA)

NASDAQ: ZURA · Real-Time Price · USD

4.040

-0.120 (-2.88%)

At close: Sep 25, 2026, 4:00 PM EDT

4.150

+0.110 (2.72%)

After-hours: Sep 25, 2026, 7:30 PM EDT

Zura Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Mar '22 Mar 31, 2022
Cash & Equivalents	205.13	109.41	176.5	99.81	1.57	4.72
Cash & Short-Term Investments	205.13	109.41	176.5	99.81	1.57	4.72
Cash Growth	32.78%	-38.01%	76.84%	6269.24%	-66.80%	-
Prepaid Expenses	5.37	2.9	2.25	1.04	0.21	-
Total Current Assets	210.5	112.31	178.74	100.84	1.78	4.72
Property, Plant & Equipment	0.15	0.13	0.09	-	-	-
Long-Term Deferred Charges	-	-	-	-	3.49	-
Other Long-Term Assets	2.75	1.51	0.7	-	-	-
Total Assets	213.4	113.95	179.53	100.84	5.26	4.72

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Mar '22 Mar 31, 2022
Accounts Payable	3.28	1.28	0.73	2.75	2.01	0.01
Accrued Expenses	10.36	11.13	9.28	7.55	0.82	-
Short-Term Debt	-	-	-	-	7.76	-
Other Current Liabilities	-	-	9.5	10	4.23	0.03
Total Current Liabilities	16.32	12.41	19.51	20.3	14.82	0.04
Other Long-Term Liabilities	-	-	-	0.99	-	-
Total Liabilities	16.32	12.41	19.51	21.29	14.82	0.04

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Mar '22 Mar 31, 2022
Common Stock	0.01	0.01	0.01	0	-	-
Additional Paid-In Capital	472.15	326.08	302.71	162.82	-	-
Retained Earnings	-275.07	-224.55	-155.9	-103.49	-32.06	-7.82
Total Common Equity	197.09	101.54	146.82	59.33	-32.06	-7.82
Minority Interest	-	-	13.2	20.22	10	-
Shareholders' Equity	197.09	101.54	160.02	79.55	-9.56	4.68
Total Liabilities & Equity	213.4	113.95	179.53	100.84	5.26	4.72

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Mar '22 Mar 31, 2022
Total Debt	-	-	-	-	7.76	-
Net Cash (Debt)	205.13	109.41	176.5	99.81	-6.19	4.72
Net Cash Growth	32.78%	-38.01%	76.84%	-	-	-
Net Cash Per Share	1.91	1.16	2.35	3.02	-27.13	-
Filing Date Shares Outstanding	95.83	94.88	68.37	43.59	43.09	17.25
Total Common Shares Outstanding	95.42	73.68	65.3	43.59	0.38	17.25
Working Capital	194.18	99.9	159.23	80.54	-13.04	4.68
Book Value Per Share	2.07	1.38	2.25	1.36	-83.59	-0.45
Tangible Book Value	197.09	101.54	146.82	59.33	-32.06	-7.82
Tangible Book Value Per Share	2.07	1.38	2.25	1.36	-83.59	-0.45

SEC Filings: 10-K · 10-Q